Company Monitoring Page for CRISPR-Therapeutics

latest headlines for company on cafepharma

Should Sangamo's Failure Make CRISPR Investors Nervous?
Motley Fool
Sun, 02/10/19 - 01:52 pm
Tags:
Sangamo Therapeutics, gene editing, CRISPR, CRISPR Therapeutics, Editas Medicine
Where Will CRISPR Therapeutics Be in 10 Years?
Motley Fool
Sun, 01/13/19 - 11:34 am
Tags:
CRISPR, gene editing, CRISPR Therapeutics
[video+transcript] Gene-Editing Stocks Took Stutter Steps Forward in 2018
Motley Fool
Tue, 12/18/18 - 10:34 am
Tags:
gene editing, Editas, Vertex Pharmaceuticals, CRISPR Therapeutics, Sangamo BioSciences
CRISPR, MaxCyte expand partnership into immuno-oncology
Pharmaceutical Business Review
Tue, 11/13/18 - 09:47 am
Tags:
CRISPR Therapeutics, MaxCyte, immuno-oncology, gene editing
Here's Why CRISPR Stocks Fell as Much as 40.7% in October
Motley Fool
Tue, 11/6/18 - 12:25 am
Tags:
CRISPR, CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics
CRISPR Therapeutics, Vertex Get FDA Green Light for Sickle Cell Test
Xconomy
Wed, 10/10/18 - 10:49 pm
Tags:
CRISPR Therapeutics, Vertex Pharmaceuticals, sickle cell disease, FDA, CTX001
CRISPR, ViaCyte Team Up to Develop Stem Cell-Based Diabetes Therapy
Xconomy
Mon, 09/17/18 - 03:18 pm
Tags:
ViaCyte, stem cells, diabetes, CRISPR Therapeutics
Amarin Corporation, CRISPR Therapeutics, and Geron Corporation could all see big gains next week
Motley Fool
Mon, 09/3/18 - 12:20 pm
Tags:
Amarin, CRISPR Therapeutics, Geron, Vascepa, Vertex Pharmaceuticals, CTX001, JNJ, imetelstat
First CRISPR clinical trial backed by U.S. companies launches
Stat
Fri, 08/31/18 - 12:03 pm
Tags:
clinical trials, CRISPR, beta thalassemia, Vertex Pharmaceuticals, CRISPR Therapeutics
Here's Why CRISPR Stocks Are Down as Much as 11.4% Today
Motley Fool
Tue, 07/24/18 - 11:43 pm
Tags:
CRISPR, CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics
CRISPR Could Cause Cancer? Here Are 3 Reasons Investors Shouldn't Panic
Motley Fool
Wed, 06/13/18 - 09:45 am
Tags:
CRISPR, CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics
Here's Why the Top CRISPR Stocks Rose as Much as 47.1% in May
Motley Fool
Fri, 06/8/18 - 11:59 pm
Tags:
CRISPR, Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics
FDA Halts Plan for Vertex, CRISPR Therapeutics Sickle Cell Study
Xconomy
Wed, 05/30/18 - 08:58 pm
Tags:
sickle cell disease, FDA, Vertex Pharmaceuticals, CRISPR Therapeutics, CTX001, stem cells
3 Great Acquisition Targets for Gilead Sciences -- and 1 Iffy Candidate
Motley Fool
Thu, 02/15/18 - 11:08 am
Tags:
Gilead Sciences, M&A, Editas, Madrigal Pharmaceuticals, CRISPR Therapeutics, Galapagos
CRISPR Recovery? “Furor” Briefly Snips $500M From Companies’ Values
Xconomy
Fri, 01/12/18 - 10:43 am
Tags:
CRISPR, CRISPR Therapeutics, Intellia Therapeutics
Disruptor Alert: These 5 Companies Are Changing Healthcare
Motley Fool
Thu, 11/16/17 - 09:23 am
Tags:
CRISPR Therapeutics, Editas Medicine, Illumina, IBM, Intellia Therapeutics, gene editing, gene sequencing, artificial intelligence
Editas loses its lead in the biotech race to launch the first CRISPR/Cas9 human study
Endpoints
Tue, 05/16/17 - 11:35 am
Tags:
Editas, CRISPR-Cas9, CRISPR Therapeutics, Intellia Therapeutics
The CRISPR patent decision: Your six takeaways
Stat
Thu, 02/16/17 - 10:13 am
Tags:
CRISPR Therapeutics, patents, CRISPR-Cas9, Broad Institute
What Happened in Biotech in 2016?
Motley Fool
Tue, 11/22/16 - 09:57 pm
Tags:
biotech, M&A, biosimilars, IPOs, Editas Medicine, CRISPR Therapeutics, Pfizer, Medivation, Celgene, Juno Therapeutics, Sarepta Therapeutics
CRISPR Therapeutics Announces Pricing of Initial Public Offering
Cafepharma/Globe Newswire
Wed, 10/19/16 - 10:42 am
Tags:
CRISPR Therapeutics, IPOs

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.